Sunday, August 18, 2019 2:54:33 PM
ATA, Inc. engages in the provision of computer-based testing services. It serves professional licensure and certification tests in various industries, which include IT services, banking, teaching, and insurance. The company was founded by Kevin Xiaofeng Ma and Walter Lin Wang in 1999 and is headquartered in Beijing, China.
SHORT INTEREST
83.41K 07/31/19
P/E Current
-3.13
P/E Ratio (with extraordinary items)
0.38
Official InvestorsHub (IHUB) Profile for TopMarketGainers.com. Since 2009,
we are the #1 Source For #FREE Winning #NASDAQ & #NYSE-Listed Alerts!
IHUB Board: https://investorshub.advfn.com/Chart-Analysis-TopMarketGainerscom-36847/
Recent ATAI News
- atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression • GlobeNewswire Inc. • 04/24/2024 11:00:38 AM
- atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology • GlobeNewswire Inc. • 04/17/2024 11:00:01 AM
- atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights • GlobeNewswire Inc. • 03/28/2024 11:00:14 AM
- atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression • GlobeNewswire Inc. • 03/27/2024 11:00:33 AM
- atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01 • GlobeNewswire Inc. • 03/04/2024 01:00:18 PM
- atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/28/2024 10:00:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:29:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 10:05:28 PM
- atai Life Sciences Appoints Anne Johnson as Chief Financial Officer • GlobeNewswire Inc. • 02/06/2024 10:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 12:46:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 10:00:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:28:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:53:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:20:38 PM
- atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics • GlobeNewswire Inc. • 01/04/2024 12:00:00 PM
- atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA) • GlobeNewswire Inc. • 01/02/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2023 02:17:41 PM
- atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights • GlobeNewswire Inc. • 11/14/2023 12:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 08:15:43 PM
- ATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORT • PR Newswire (Canada) • 10/10/2023 12:00:00 PM
- atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit • GlobeNewswire Inc. • 10/06/2023 08:05:00 PM
- atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants • GlobeNewswire Inc. • 10/02/2023 08:13:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:38:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/14/2023 08:30:13 PM
- atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference • GlobeNewswire Inc. • 09/14/2023 12:02:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM